Inovalis Real Estate Investment Trust Company Profile (TSE:INO)

About Inovalis Real Estate Investment Trust

Inovalis Real Estate Investment Trust logoInovio Pharmaceuticals, Inc. (Inovio) is a bio-pharmaceutical company, which is involved in developing deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on treating and preventing cancers and infectious diseases. The Company's DNA-based immunotherapies, in combination with its electroporation delivery devices, generates immune responses, in particular T cells, in the body to fight target diseases. It has completed, current or planned clinical programs of its SynCon immunotherapies for human papillomavirus (HPV)-caused pre-cancers and cancers, breast/lung/pancreatic cancer, hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), influenza, Ebola, Middle East respiratory syndrome (MERS) and Zika virus. With its immunotherapy platform, as well as with its CELLECTRA electroporation delivery technology, the Company has a pipeline of pre-clinical and clinical stage products that have generated in vivo (in the body) immune responses.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: TSE
  • Symbol: INO
  • CUSIP:
Key Metrics:
  • Previous Close: $0.00
  • 50 Day Moving Average: $N/A
  • 200 Day Moving Average: $N/A
  • Trailing P/E Ratio: N/A
  • P/E Growth: N/A
  • Market Cap: $N/A
Additional Links:

Analyst Ratings

Consensus Ratings for Inovalis Real Estate Investment Trust (TSE:INO) (?)
Ratings Breakdown: 1 Hold Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: N/A

Analysts' Ratings History for Inovalis Real Estate Investment Trust (TSE:INO)
Show:
DateFirmActionRatingPrice TargetDetails
5/25/2016National Bank FinancialDowngradeOutperform Market Weight -> Sector Perform Market WeightView Rating Details
3/28/2016DesjardinsDowngradeBuy -> HoldView Rating Details
(Data available from 9/30/2014 forward)

Earnings

Earnings History for Inovalis Real Estate Investment Trust (TSE:INO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/18/2014$0.22$0.22ViewN/AView Earnings Details
5/9/2014$0.20$0.23ViewN/AView Earnings Details
3/22/2014$0.20$0.24ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Inovalis Real Estate Investment Trust (TSE:INO)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.25$0.25$0.25
Q2 20162$0.23$0.24$0.24
Q3 20162$0.20$0.23$0.22
Q4 20161$0.21$0.21$0.21
Q1 20171$0.25$0.25$0.25
Q2 20171$0.26$0.26$0.26
Q3 20171$0.26$0.26$0.26
Q4 20171$0.26$0.26$0.26
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Inovalis Real Estate Investment Trust (TSE:INO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Inovalis Real Estate Investment Trust (TSE:INO)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Inovalis Real Estate Investment Trust (TSE:INO)
DateHeadline
News IconInvestors Real Estate Trust (NYSE:IRET) Updated Price Targets (TSE:INO)
www.crcconnection.com - September 14 at 9:52 AM

Social

Inovalis Real Estate Investment Trust (TSE:INO) Chart for Friday, September, 30, 2016


Last Updated on 9/30/2016 by MarketBeat.com Staff